Skip to content

A clinical trial evaluating the safety and efficacy of robot-assisted thoracic, abdominal, and pelvic surgeries performed using the single-port laparoscopic endoscopic surgical system (SA-1000)

A clinical trial evaluating the safety and efficacy of robot-assisted thoracic, abdominal, and pelvic surgeries performed using the single-port laparoscopic endoscopic surgical system (SA-1000)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110496
Enrollment
Unknown
Registered
2025-10-14
Start date
2025-10-15
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Surgery, Urology Surgery, Gynecology Surgery, and Thoracic Surgery Disorders

Interventions

Experimental group:Intraperitoneal single-port surgical system

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age ranging from 18 years to 80 years; 2) Those requiring endoscopic surgeries for the chest, abdomen, and pelvic region, including but not limited to the following procedures: a) General Surgery: Radical gastrectomy for distal gastric cancer, radical colorectal cancer resection, liver resection/spleen resection; b) Urology: Partial nephrectomy (via abdominal cavity or retroperitoneum), radical prostatectomy; c) Gynecology: Radical hysterectomy (including pelvic lymph node dissection), hysterectomy; d) Thoracic Surgery: Segmental/lung lobe resection, esophageal cancer radical resection, mediastinal tumor resection. 3) Physically capable of undergoing laparoscopic surgery. 4) Willing to cooperate and complete the study follow-up and related examinations. 5) The subjects or their agents voluntarily participate in this trial and sign the informed consent form in person.

Exclusion criteria

Exclusion criteria: 1) Pregnant or lactating women. 2) Those requiring emergency surgery. 3) Presenting with active bleeding, severe abnormal coagulation function (prothrombin time (PT) or international normalized ratio (INR) more than twice the upper limit of normal value) or platelet count < 50×10^9/L. 4) Having severe cardiovascular or circulatory diseases and unable to tolerate surgery. 5) Having participated in other clinical trials within the last 1 month. 6) Unable to understand the trial requirements or unable to complete the study follow-up plan. 7) The investigator considers there are other circumstances that make them ineligible for enrollment.

Design outcomes

Primary

MeasureTime frame
Surgical success rate;

Secondary

MeasureTime frame
time of operation;peroperative bleeding;The amount of blood transfused during the operation;Postoperative hospital stay;Postoperative incision aesthetic evaluation;Postoperative patient pain score;

Countries

China

Contacts

Public ContactZhongtao Zhang/Gangyue Hao

Beijing Friendship Hospital,Capital MedicalUniversity

zhangzht@ccmu.edu.can+86 10 6313 8475

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026